Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
Login | Create an Account

SCSHP Annual Meeting 2020 (Pharmacy Technicians)


 
SCSHP 2020 Annual Meeting
Thursday, March 12 - Friday March 13, 2020
 
To register and view the full meeting agenda, visit https://www.scshp.com/events/EventDetails.aspx?id=1254736! 
 
Location:  North Charleston Marriott, 4770 Goer Drive North Charleston, South Carolina 29406 
 
For all continuing education session details, including speakers and learning objectives, please expand the individual sessions below!  

Date: Mar 12, 2020 08:00 AM - Mar 13, 2020 05:45 PM

Fee

$0.00

CE Hours

15.00

CE Units

1.500

Activity Type

  • Knowledge-Based and Application-Based

Target Audience(s)

  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

SCSHP

Requirements for CE Credit

In order to claim credit and have CE credit submitted to the CPE Monitor, participants must complete the following steps within 60 days of the event.  Completion of these steps within 30 days of the event will allow for any issues in transmission to NABP to be rectified by our office. The CPE Monitor will not accept credit that is submitted greater than 60 days after the event per NABP policy.
  1. Check in upon arrival at the meeting
  2. Complete and submit the "CE Sign In" form at the meeting
  3. Complete the online program evaluations
  4. Provide the correct month and day of birth and NABP e-Profile ID.  Registration with a proper disclosure of your NABP E-Profile ID is a requirement for receiving Continuing Pharmacy Education.  To register with or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site.  

 

 

 

 

At the completion of this activity, the pharmacist will be able to:
  1. Define burnout, well-being, and resilience
  2. Explain why clinician burnout is a patient care and healthcare workforce problem
  3. Discuss the U.S. National Academy of Medicine Clinician Well-Being and Resilience Action Collaborative and consensus study
  4. Identify strategies to improve well-being and resilience in the healthcare workforce

Speaker(s)/Author(s)

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon), FASHP
Chief Executive Officer, ASHP

Activity Number

0062-9999-20-084-L04-T
Date: 03/12/20
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Recognize that diversity promotes healthier leadership and decision-making;
  2. Define implicit biases and their pervasiveness
  3. Examine the impact of mitigating implicit bias on decisions in healthcare and education

Speaker(s)/Author(s)

B. DaNine Fleming, EdS, EdD
Associate Professor, Director of Training and Intercultural Education, and Unconscious Bias Faculty Scholar, MUSC

Activity Number

0062-9999-20-085-L04-T
Date: 03/12/20
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Identify the importance of infectious diseases treatment guidelines and policies
  2. Recognize newly approved antimicrobials
  3. Identify emerging pathogens both nationally and globally
  4. Examine opportunities for pharmacy technicians to impact the management of infectious diseases

Speaker(s)/Author(s)

P. Brandon Bookstaver, PharmD, FCCP, FIDSA
Associate Professor and Director of Residency & Fellowship Training, UofSC COP; Infectious Diseases Pharmacist, Infectious Diseases PGY2 & Clinical Fellowship Director, Prisma Health Richland

Activity Number

0062-9999-20-086-L01-T
Date: 03/12/20
Time: 10:30 AM - 11:30 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Recognize high-dose intravenous thiamine replacement
  2. Identify when a short-course corticosteroid regimen may require a taper
  3. Explain the unreliability of subgroup analyses

Speaker(s)/Author(s)

Kathryn Rice, PharmD, BCPS
Assistant Professor of Pharmacy Practice, South University School of Pharmacy

Activity Number

0062-9999-20-087-L01-T
Date: 03/12/20
Time: 11:30 AM - 01:00 PM

CE Hours

1.50
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Explain the mechanism of action for sodium glucose co-transporter 2 (SGLT-2) inhibitors
  2. Summarize the potential benefit of SGLT-2 inhibitors on heart failure (HF) outcomes
  3. Determine appropriate counseling points with a SGLT-2 inhibitor for a patient with type 2 diabetes mellitus (T2DM) and HF

Speaker(s)/Author(s)

Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM
Clinical Professor and Director of Pharmacy Education, University of South Carolina College of Pharmacy

Activity Number

0062-9999-20-088-L01-T
Date: 03/12/20
Time: 01:30 PM - 02:30 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Recall pharmacy trivia related to pharmacology, pharmacokinetics, pharmacodynamics, pharmacogenomics, clinical pharmacy history, biostatistics, and health outcomes
  2. Summarize clinical knowledge in response to a case vignette using supporting laboratory, physical examination, and medical history information
  3. Discuss numerous drug therapy and specialty areas through response to pharmacotherapy questions

Speaker(s)/Author(s)

P. Brandon Bookstaver, PharmD, FCCP, FIDSA
Associate Professor and Director of Residency & Fellowship Training, UofSC COP; Infectious Diseases Pharmacist, Infectious Diseases PGY2 & Clinical Fellowship Director, Prisma Health Richland

Activity Number

0062-9999-20-089-L01-T
Date: 03/12/20
Time: 02:30 PM - 03:30 PM

CE Hours

1.00
 

 

  • Effect of pharmacist-led educational interventions on proton pump inhibitor de-prescribing in an inpatient psychiatric facility – Anju Balani, PharmD Candidate, Presbyterian College School of Pharmacy
  • Cyclin-dependent kinase 8/19 inhibitors suppress the metastatic growth of secondary tumor cells ex vivo – Stephan Bowe, PharmD Candidate, USC College of Pharmacy
  • Comparative Monte Carlo analysis of cefepime/VNRX-5133 and meropenem/vaborbactam against resistant Gram-negative pathogens – Meghan White, PharmD Candidate, MUSC College of Pharmacy
 
At the completion of this activity, the pharmacist will be able to:
  1. Discuss emerging research outcomes from throughout the state of South Carolina
  2. Recognize novel ideas for research and quality initiative projects in your pharmacy practice areas
  3. Review pivotal results from local investigations across the state of South Carolina

Activity Number

0062-9999-20-090-L04-T
Date: 03/12/20
Time: 04:00 PM - 05:00 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Recall pharmacy trivia related to pharmacology, pharmacokinetics, pharmacodynamics, pharmacogenomics, clinical pharmacy history, biostatistics, and health outcomes
  2. Summarize clinical knowledge in response to a case vignette using supporting laboratory, physical examination, and medical history information
  3. Discuss numerous drug therapy and specialty areas through response to pharmacotherapy questions

Speaker(s)/Author(s)

P. Brandon Bookstaver, PharmD, FCCP, FIDSA
Associate Professor and Director of Residency & Fellowship Training, UofSC COP; Infectious Diseases Pharmacist, Infectious Diseases PGY2 & Clinical Fellowship Director, Prisma Health Richland

Activity Number

0062-9999-20-091-L01-T
Date: 03/12/20
Time: 05:00 PM - 05:30 PM

CE Hours

0.50
 

 

 

At the completion of this activity, the pharmacist will be able to:
  1. Review the history of opioid use and the impact of the current opioid epidemic in the U.S.
  2. Discuss pain management strategies that health care practitioners can use in light of the opioid epidemic
  3. Review the path to opioid use disorder (OUD) and key preventative strategies that everyone can employ to reduce the risk of opioid overdose

Speaker(s)/Author(s)

Doug Furmanek, PharmD, BCCP
Director, Clinical Pharmacy Services, Prisma Health - Upstate

Activity Number

0062-9999-20-095-L08-T
Date: 03/13/20
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Recognize newer, carbapenem-sparing agents for the treatment of resistant Gram-negative bloodstream infections (BSI)
  2. Discuss use of oral antibiotics in BSIs

Speaker(s)/Author(s)

Krutika N. Mediwala, PharmD, BCPS, BCIDP
Clinical Pharmacy Specialist – Infectious Diseases/Antimicrobial Stewardship; Residency Program Director, PGY2 Infectious Diseases Residency, MUSC Health

Activity Number

0062-9999-20-096-L01-T
Date: 03/13/20
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Discuss Advanced Cardiac Life Support (ACLS) algorithms per the American Heart Association (AHA) guidelines
  2. Recognize interventions in cardiac arrest which are most likely to positively impact patient outcomes
  3. Describe the possible future of cardiac arrest care based on emerging evidence

Speaker(s)/Author(s)

Elizabeth Robinette, PharmD, BCCCP
Trauma Surgical ICU Pharmacy Specialist, McLeod Health

Activity Number

0062-9999-20-097-L01-T
Date: 03/13/20
Time: 10:30 AM - 11:30 AM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Recognize current dosing strategies for ascorbic acid, thiamine, and angiotensin II
  2. Describe the cost and preparation concerns for ascorbic acid, thiamine, and angiotensin II
  3. List the possible pros and cons of using ascorbic acid, thiamine, and angiotensin II for a patient with septic shock

Speaker(s)/Author(s)

Carolyn A. Magee, PharmD, BCCCP
Clinical Pharmacy Specialist-Medical Surgical ICU, Medical University of South Carolina

Activity Number

0062-9999-20-098-L01-T
Date: 03/13/20
Time: 11:30 AM - 12:30 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Define germ theory of disease
  2. Discuss handwashing technique
  3. Discuss hand sanitizer application technique

Speaker(s)/Author(s)

Candice B. Geiger, M.Ed, CPhT
Pharmacy Technician Program Director, Midlands Technical College

Activity Number

0062-9999-20-102-L05-T
Date: 03/13/20
Time: 02:30 PM - 03:30 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Define complementary, alternative and integrative medicine practices
  2. Discuss the regulation of natural products, including associated laws that govern the sale of natural products
  3. Discuss legal implications associated with the use and sale of CBD

Speaker(s)/Author(s)

Kristy Brittain, PharmD, BCPS, CDCES
Associate Professor, Clinical Pharmacy Specialist, Director of PGY1 Community-Based Pharmacy Residency, MUSC College of Pharmacy

Activity Number

0062-9999-20-030-L03-T
Date: 03/13/20
Time: 03:45 PM - 04:45 PM

CE Hours

1.00
 

 

At the completion of this activity, the pharmacist will be able to:
  1. Identify new medications and devices for use in asthma and COPD
  2. Discuss associated drug information for medications and devices regarding storage, administration, dispensing and adherence
  3. Discuss the role of the pharmacy technician in improving patient adherence to asthma and COPD medications

Speaker(s)/Author(s)

Kristy Brittain, PharmD, BCPS, CDCES
Associate Professor, Clinical Pharmacy Specialist, Director of PGY1 Community-Based Pharmacy Residency, MUSC College of Pharmacy

Activity Number

0062-9999-20-033-L01-T
Date: 03/13/20
Time: 04:45 PM - 05:45 PM

CE Hours

1.00
 



 
University of South Carolina College of Pharmacy | 715 Sumter Street, Coker Life Sciences, Columbia, SC 29208 | 803-777-9979 | CE@cop.sc.edu
 
Powered By: Learning ExpressCE
Copyright © 2024 UofSC College of Pharmacy Continuing Education. All Rights Reserved.
About Us Privacy Policy Terms of Service